CARDINAL HEALTH, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 98.91 USD | -3.95% |
|
-4.17% | -1.88% |
| May. 03 | Wells Fargo Raises Cardinal Health's Price Target to $95 From $94 | MT |
| May. 03 | Baird Adjusts Price Target on Cardinal Health to $128 From $134 | MT |
Financials (USD)
| Sales 2024 * | 226B | Sales 2025 * | 222B | Capitalization | 24.09B |
|---|---|---|---|---|---|
| Net income 2024 * | 955M | Net income 2025 * | 1.45B | EV / Sales 2024 * | 0.1 x |
| Net cash position 2024 * | 539M | Net cash position 2025 * | 1.28B | EV / Sales 2025 * | 0.1 x |
| P/E ratio 2024 * |
19.5
x | P/E ratio 2025 * |
15.6
x | Employees | 47,520 |
| Yield 2024 * |
2.04% | Yield 2025 * |
2.09% | Free-Float | 74.05% |
More Fundamentals
* Assessed data
More news
Latest transcript on Cardinal Health, Inc.
More recommendations
More press releases
| 1 day | -3.95% | ||
| 1 week | -4.17% | ||
| Current month | -4.01% | ||
| 1 month | -10.84% | ||
| 3 months | -4.40% | ||
| 6 months | -1.30% | ||
| Current year | -1.88% |
1 week
98.24
106.68
1 month
98.24110.96
Current year
98.24116.04
1 year
80.90116.04
3 years
45.85116.04
5 years
39.05116.04
10 years
39.05116.04
| Managers | Title | Age | Since |
|---|---|---|---|
Jason Hollar
CEO | Chief Executive Officer | 51 | 20-04-26 |
Aaron Alt
DFI | Director of Finance/CFO | 53 | 23-02-09 |
Michelle Greene
CTO | Chief Tech/Sci/R&D Officer | 54 | 20-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 55 | 22-09-05 | |
| Director/Board Member | 71 | 13-09-11 | |
Gregory Kenny
CHM | Chairman | 71 | 06-12-31 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-03 | 98.91 | -3.95% | 3,446,183 |
| 24-05-02 | 103 | +0.79% | 3,684,813 |
| 24-05-01 | 102.2 | -0.84% | 2,858,908 |
| 24-04-30 | 103 | +0.13% | 2,456,082 |
| 24-04-29 | 102.9 | -0.29% | 1,690,855 |
Delayed Quote Nyse, May 03, 2024 at 04:00 pm EDT
More quotes
Cardinal Health, Inc. is specialized in the distribution of products and health services to pharmacies, hospitals and medical practices. Net sales break down by activity as follows:
- distribution of pharmaceutical products (92.7%);
- distribution of medical, surgical and laboratory products (7.3%). The group also develops a manufacturing of medical and surgical products activity (masks, overalls, gloves, diagnostic products, products of aspiration and collection of liquids, radiology intervention, respiratory assistance, etc.).
The United States accounts for 97.7% of net sales.
Sector
Pharmaceuticals
Calendar
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
98.91
USD
Average target price
112.9
USD
Spread / Average Target
+14.11%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -1.88% | 24.09B | |
| +14.23% | 69.5B | |
| +7.11% | 8.2B | |
| -20.55% | 7.97B | |
| -4.06% | 7.84B | |
| +2.26% | 4.66B | |
| +17.12% | 4.32B | |
| +1.41% | 4.19B | |
| -3.02% | 3.89B | |
| +21.42% | 3.62B |
- Stock Market
- Equities
- CAH Stock
